Quantcast

Latest Drug-eluting stent Stories

2014-05-23 08:23:56

-- Sustained Safety Profile -- DURHAM, N.C., May 23, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that long-term clinical outcomes from its DESSOLVE I and II clinical trials were presented at the EuroPCR conference in Paris, France this week. Presentations by principal investigator William Wijns, M.D., Ph.D. of the Cardiovascular Center in Aalst, Belgium, highlighted results of long-term clinical follow-up of the MiStent Sirolimus Eluting Absorbable Polymer Coronary...

2014-05-23 04:20:45

COMBO(TM) Dual Therapy Stent shown to actively promote rapid endothelialization and deliver long-term, true vessel healing HONG KONG, May 23, 2014 /PRNewswire/ -- OrbusNeich today announced long-term results from its REMEDEE Trial. In addition to showing that the COMBO(TM) Dual Therapy Stent shows no late target lesion revascularization, the results demonstrate that the stent proactively promotes functional vessel healing. Key findings include: -...

2014-05-22 16:23:52

LONDON, May 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Intravascular Ultrasound (IVUS) Industryhttp://www.reportbuyer.com/pharma_healthcare/technology/intravascular_ultrasound_ivus.htmlThis report analyzes the worldwide markets for Intravascular Ultrasound (IVUS) in US$ Thousand by the following Product Segments: Intravascular Ultrasound (IVUS) Catheters, and Intravascular Ultrasound (IVUS) Consoles. The report provides separate...

2014-05-21 08:29:14

EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile NATICK, Mass., May 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the SYNERGY(TM) Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium (PtCr) Coronary Stent System to the PROMUS Element(TM) Stent System. The data were presented today at EuroPCR 2014 by...

2014-05-20 08:33:34

Company to Present at European Symposium Titled MGuard(TM) Embolic Protection Stent: The Importance of Thrombus Management in STEMI Primary PCI BOSTON, May 20, 2014 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it will be attending EuroPCR 2014, the leading cardiovascular event in Europe. The conference will take place in Paris, France from May 20-23, 2014. Each year, more than 120...

2014-05-15 16:28:10

-- Oral Presentations to Include New Long-Term Results from First-in-Human Study -- DURHAM, N.C., May 15, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced the updated three- and two-year clinical outcomes from its DESSOLVE I and II clinical trials, respectively, will be presented at the EuroPCR conference to be held in Paris, France from May 20 - 23. Two oral presentations will be made by William Wijns, M.D., Ph.D., Cardiovascular Center, Aalst, Belgium: -- DESSOLVE II...

2014-05-05 08:28:39

SINGAPORE, May 5, 2014 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, announced today that the U.S. Food and Drug Administration (FDA) recently granted conditional Investigational Device Exemption (IDE) approval for a U.S.-based clinical trial of the BioFreedom(TM) polymer-free drug-coated stent (DCS) system. The BioFreedom U.S....

2014-05-01 00:21:42

NATICK, Mass., May 1, 2014 /PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan. This advanced DES system recently received Japan Ministry of Health, Labor and Welfare (MHLW) approval. "It is my great pleasure to be able to provide the Promus PREMIER(TM) Stent System to physicians and patients in Japan,"...

2014-04-10 08:30:25

- First-of-its-Kind Dissolving Medical Device Being Evaluated in People with Blocked Heart Vessels ABBOTT PARK, Ill., April 10, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has completed enrollment of three clinical trials to support approvals of the company's revolutionary Absorb(TM) Bioresorbable Vascular Scaffold (BVS) in the United States, Japan and China. Combined, the U.S., Japan and China account for more than 50 percent of the world's heart stent market....

2014-04-08 12:32:43

DALLAS, April 8, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Market Research Report on Global and China Coronary Stent Industry" and "2014 Deep Research Report on Global and China Breast Localization Wire Industry" reports to its research database. (Photo: http://photos.prnewswire.com/prnh/20140408/MN00510) 2014 Market Research Report on Global and China Coronary Stent Industry" is a professional and in-depth research report on China and Global coronary stent...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related